×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MBOT – microbot medical inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MBOT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/14
02:30 pm
mbot
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
4/14
08:00 am
mbot
Microbot Medical (MBOT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Microbot Medical (MBOT) had its "buy" rating reaffirmed by HC Wainwright. They now have a $12.00 price target on the stock.
4/13
08:30 am
mbot
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
Low
Report
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
4/13
06:01 am
mbot
Microbot Medical (MBOT) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Low
Report
Microbot Medical (MBOT) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
3/26
08:30 am
mbot
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
Medium
Report
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
3/24
08:30 am
mbot
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
Low
Report
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
3/17
09:05 am
mbot
Microbot Medical® to Participate at the 38th Annual Roth Conference [Yahoo! Finance]
Low
Report
Microbot Medical® to Participate at the 38th Annual Roth Conference [Yahoo! Finance]
3/17
08:40 am
mbot
Microbot Medical® to Participate at the 38th Annual Roth Conference
Low
Report
Microbot Medical® to Participate at the 38th Annual Roth Conference
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/14
08:30 am
mbot
Form 8-K Microbot Medical Inc. For: Apr 14
Low
Report
Form 8-K Microbot Medical Inc. For: Apr 14
4/13
08:30 am
mbot
Form 8-K Microbot Medical Inc. For: Apr 13
Low
Report
Form 8-K Microbot Medical Inc. For: Apr 13
4/10
05:10 pm
mbot
Form 424B5 Microbot Medical Inc.
Medium
Report
Form 424B5 Microbot Medical Inc.
4/10
05:00 pm
mbot
Form 8-K Microbot Medical Inc. For: Apr 10
High
Report
Form 8-K Microbot Medical Inc. For: Apr 10
4/3
04:31 pm
mbot
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Wilson David James
Low
Report
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Wilson David James
4/3
04:31 pm
mbot
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Madden Martin J.
Low
Report
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Madden Martin J.
4/3
04:31 pm
mbot
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Wenderow Tal Baruch
Low
Report
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Wenderow Tal Baruch
4/3
04:31 pm
mbot
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Stockburger Aileen Ptucha
Low
Report
Form 4 Microbot Medical Inc. For: Apr 01 Filed by: Stockburger Aileen Ptucha
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/23
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures
74.9%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
9/5 Microbot Medical to Demonstrate a Working Prototype of its Self-Cleaning Shunt at the Rodman & Renshaw Annual Global Investment Conference 41.2%
12/24 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, up previously from $10.00. 23.1%
2/21 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 16.9%
1/2 Form SC 13D/A Microbot Medical Inc. Filed by: Gadot Harel 12.5%
12/26 Form 4 Microbot Medical Inc. For: Dec 23 Filed by: Gadot Harel 11.3%
3/17 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.4%
9/11 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock. 5.6%
10/30 Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT™ Technology Platform 5.1%
7/22 Microbot Medical Inc (NASDAQ: MBOT) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.0%
TOP News Decliners
12/27
Form 424B5 Microbot Medical Inc.
-24.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
12/26 Microbot Medical Inc. Announces $9.59 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -21.5%
12/30 Microbot Medical Inc. Announces $10.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules -16.9%
9/10 Microbot Medical Inc (NASDAQ: MBOT) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -15.3%
1/13 Form 8-K Microbot Medical Inc. For: Jan 13 -14.6%
4/1 Microbot Medical Appoints Aileen Stockburger to the Board of Directors -11.5%
12/11 Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers [Seeking Alpha] -10.9%
12/31 Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock -8.0%
10/30 Form 8-K Microbot Medical Inc. For: Oct 30 -7.5%
5/1 Microbot Medical Inc (NASDAQ: MBOT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $26.00. -7.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: